Eurofins Scientific Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Gilles Martin
Chief executive officer
€1.4m
Total compensation
| CEO salary percentage | 97.6% |
| CEO tenure | 36.3yrs |
| CEO ownership | 0.00001% |
| Management average tenure | no data |
| Board average tenure | 8.5yrs |
Recent management updates
We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Apr 19
How Does Eurofins Scientific's (EPA:ERF) CEO Pay Compare With Company Performance?
Dec 14
Recent updates
We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Apr 19Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings
Apr 18Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?
Nov 10Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price
Oct 23We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt
Aug 07Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?
Jul 20We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt
May 03Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate
Apr 11Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)
Jan 05Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly
Dec 14An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued
Oct 03Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?
Sep 06Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00
Jun 25Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?
Jun 16Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Jun 01Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?
Apr 12These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely
Feb 25Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?
Nov 28Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Nov 14Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today
Sep 30Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?
Aug 29We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease
Aug 15Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?
Jun 24Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)
May 25Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet
Mar 31Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?
Mar 17Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock
Mar 03Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Mar 03Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?
Feb 15Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?
Dec 28How Does Eurofins Scientific's (EPA:ERF) CEO Pay Compare With Company Performance?
Dec 14Eurofins Scientific (EPA:ERF) Is Growing Earnings But Are They A Good Guide?
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €1m | €1m | €257m |
| Sep 30 2023 | n/a | n/a | €335m |
| Jun 30 2023 | n/a | n/a | €414m |
| Mar 31 2023 | n/a | n/a | €497m |
| Dec 31 2022 | €1m | €1m | €581m |
| Sep 30 2022 | n/a | n/a | €612m |
| Jun 30 2022 | n/a | n/a | €643m |
| Mar 31 2022 | n/a | n/a | €696m |
| Dec 31 2021 | €1m | €1m | €749m |
| Sep 30 2021 | n/a | n/a | €786m |
| Jun 30 2021 | n/a | n/a | €824m |
| Mar 31 2021 | n/a | n/a | €665m |
| Dec 31 2020 | €1m | €1m | €505m |
| Sep 30 2020 | n/a | n/a | €347m |
| Jun 30 2020 | n/a | n/a | €190m |
| Mar 31 2020 | n/a | n/a | €168m |
| Dec 31 2019 | €1m | €1m | €146m |
| Sep 30 2019 | n/a | n/a | €144m |
| Jun 30 2019 | n/a | n/a | €143m |
| Mar 31 2019 | n/a | n/a | €159m |
| Dec 31 2018 | €1m | €1m | €175m |
Compensation vs Market: Gilles's total compensation ($USD1.45M) is below average for companies of similar size in the French market ($USD4.74M).
Compensation vs Earnings: Gilles's compensation has been consistent with company performance over the past year.
CEO
Gilles Martin (60 yo)
36.3yrs
Tenure
€1,351,000
Compensation
Dr. Gilles G. Martin, Ph D., serves as the Chief Executive Officer at Eurofins Scientific, Inc. Dr. Martin serves as Chief Executive Officer of Eurofins Nihon Kankyo K.K. and Eurofins Scientific Group. He...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 36.3yrs | €1.35m | 0.000010% € 1.2k | |
| Executive Director | 34.3yrs | €400.69k | 0.000010% € 1.2k | |
| Non-Executive Director | 32.3yrs | €33.00k | 0.076% € 9.0m | |
| Independent Non-Executive Director | 7yrs | €71.50k | no data | |
| Independent Non-Executive Director | 3yrs | €55.00k | no data | |
| Independent Non-Executive Director | 10yrs | €44.00k | 0.0033% € 389.7k | |
| Independent Non-Executive Director | 3yrs | €66.00k | 0.00031% € 36.8k | |
| Lead Independent Non-Executive Director | 3.8yrs | €93.50k | no data |
8.5yrs
Average Tenure
59.5yo
Average Age
Experienced Board: ERF's board of directors are considered experienced (8.5 years average tenure).